The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib (REG) in patients (pts) with nonadipocytic soft tissue sarcoma (STS) previously treated with pazopanib (PAZ).
 
Nicolas Penel
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar
 
Jean-Yves Blay
Honoraria - Bayer
Research Funding - Bayer
 
Jennifer Wallet
No Relationships to Disclose
 
Isabelle Laure Ray-Coquard
Honoraria - AstraZeneca; Clovis Oncology; MSD Oncology; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Abbvie; Amgen; Genmab; Pfizer
Travel, Accommodations, Expenses - Roche
 
Axel Le Cesne
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar
 
Thomas Ryckewaert
No Relationships to Disclose
 
Antoine Italiano
Honoraria - Bayer; Daiichi Sankyo; Epizyme; Lilly; Novartis; Roche
Consulting or Advisory Role - Bayer; Daiichi Sankyo; Epizyme; Immune Design; Lilly; Roche
Research Funding - AstraZeneca/MedImmune; Bayer; Merck Serono; Merck Serono; MSD Oncology; PharmaMar; Roche
 
Sebastien Salas
No Relationships to Disclose
 
Corinne Delcambre
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Francois Bertucci
No Relationships to Disclose
 
Esma Saada-Bouzid
No Relationships to Disclose
 
Loic Chaigneau
No Relationships to Disclose
 
Christine Chevreau
No Relationships to Disclose
 
Julien Thery
No Relationships to Disclose
 
Emilie Decoupigny
No Relationships to Disclose
 
Marie Vanseymortier
No Relationships to Disclose
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Olivier Mir
Stock and Other Ownership Interests - Transgene
Honoraria - Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; SERVIER; Vifor Pharma
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - Pfizer; PharmaMar; Roche